Conference
Benefits of candesartan are consistent regardless of pre-treatment systolic blood pressure in the candesartan in heart failure: Assessment of reduction in mortality and morbidity (CHARM) program.
Authors
Meredith PA; Ostergren J; McMurray JJV; Granger CB; Swedberg K; Yusuf S; Michelson EL; Olofsson B; Puu M; Solomon SD
Volume
49
Pagination
pp. 331A-331A
Publisher
ELSEVIER SCIENCE INC
Publication Date
March 6, 2007
Name of conference
56th Annual Scientific Session of the American-College-of-Cardiology
Conference place
New Orleans, LA
Conference start date
March 24, 2007
Conference end date
March 27, 2007
Conference proceedings
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Issue
9
ISSN
0735-1097